Cosentyx and PERIPHERAL SWELLING

5,391 reports of this reaction

1.1% of all Cosentyx reports

#19 most reported adverse reaction

Overview

PERIPHERAL SWELLING is the #19 most commonly reported adverse reaction for Cosentyx, manufactured by Novartis Pharmaceuticals Corporation. There are 5,391 FDA adverse event reports linking Cosentyx to PERIPHERAL SWELLING. This represents approximately 1.1% of all 494,338 adverse event reports for this drug.

Patients taking Cosentyx who experience peripheral swelling should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PERIPHERAL SWELLING5,391 of 494,338 reports

PERIPHERAL SWELLING is a less commonly reported adverse event for Cosentyx, but still significant enough to appear in the safety profile.

Other Side Effects of Cosentyx

In addition to peripheral swelling, the following adverse reactions have been reported for Cosentyx:

Frequently Asked Questions

Does Cosentyx cause PERIPHERAL SWELLING?

PERIPHERAL SWELLING has been reported as an adverse event in 5,391 FDA reports for Cosentyx. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PERIPHERAL SWELLING with Cosentyx?

PERIPHERAL SWELLING accounts for approximately 1.1% of all adverse event reports for Cosentyx, making it a notable side effect.

What should I do if I experience PERIPHERAL SWELLING while taking Cosentyx?

If you experience peripheral swelling while taking Cosentyx, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.